Fees Should Be A Last Resort For NICE Funding, Says UK Medtechs

UK industry has given its rationale for opposing health technology assessment fees from NICE, but suggests that it might be prepared to discuss the general theme of NICE funding if the conditions were right.

The proposal from the UK National Institute for Health and Care Excellence (NICE) to raise fees from its guidance-setting work has drawn a guarded response from the UK medical technology industry association, ABHI.

ABHI voiced it opposition to these fees earlier this week, both on principal and on economic grounds

More from United Kingdom

More from Europe